BPTS Stock Performance, Insider Transaction and News

BPTS - Biophytis SA

Market Cap	8.35M	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-17.03M	Forward P/E	-	EPS next Y	-	50D Avg Chg	-42.00%
Sales	-	PEG	-	EPS past 5Y	-	200D Avg Chg	-66.00%
Dividend	N/A	Price/Book	N/A	EPS next 5Y	-	52W High Chg	-90.00%
Recommedations	2.00	Quick Ratio	0.65	Shares Outstanding	286.50K	52W Low Chg	13.00%
Insider Own	-	ROA	-52.78%	Shares Float	1.11B	Beta	1.05
Inst Own	0.05%	ROE	-	Shares Shorted/Prior	9.22K/1.07K	Price	1.37
Gross Margin	-	Profit Margin	-	Avg. Volume	281,408	Target Price	6,000.00
Oper. Margin	-	Earnings Date	-	Volume	320,480	Change	-20.81%

Healthcare | Biotechnology | France

About Biophytis SA

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.

BPTS Chatroom

Medpower Posted - 09/25/24

$BPTS why this one is on otc market?

Stock_Titan Posted - 4 months ago

$BPTS Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in Asia https://www.stocktitan.net/news/BPTS/biophytis-deploys-its-partnership-strategy-and-signs-two-contracts-qbza06b9fcsm.html

Stock_Titan Posted - 4 months ago

$BPTS Biophytis Obtains IND Approval from the FDA to Start its Phase 2 OBA Study in Obesity https://www.stocktitan.net/news/BPTS/biophytis-obtains-ind-approval-from-the-fda-to-start-its-phase-2-oba-iqssxto2z0d9.html

Jamestocksdn Posted - 4 months ago

$BPTS we are waiting 2

tradingtwenty Posted - 4 months ago

Top 5 stocks by smallest market cap that have trended in the past 24 hours: $LGHL 1.67M 🔥 $NUWE 2.59M $BPTS 2.61M $RELI 3.31M $HSCSNM 3.42M Link: https://tradingtwenty.com/dashboard/trending/past

Stock_Titan Posted - 4 months ago

$BPTS Biophytis Presented its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris https://www.stocktitan.net/news/BPTS/biophytis-presented-its-phase-2-3-cova-study-results-in-severe-forms-i7dc26e4tsxg.html

Stock_Titan Posted - 5 months ago

$BPTS Biophytis grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million https://www.stocktitan.net/news/BPTS/biophytis-grants-blanver-exclusive-rights-to-bio101-in-latin-america-nuazur6x0zom.html

Stock_Titan Posted - 5 months ago

$BPTS Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business Activities https://www.stocktitan.net/news/BPTS/biophytis-extends-its-contract-with-atlas-to-secure-financing-for-t0u1zsgoiojc.html

Stock_Titan Posted - 5 months ago

$BPTS Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by its Service Provider Seqens https://www.stocktitan.net/news/BPTS/biophytis-announces-the-successful-industrial-transfer-of-bio101-20-sm0c5xfa050b.html

Stock_Titan Posted - 6 months ago

$BPTS Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity https://www.stocktitan.net/news/BPTS/biophytis-announces-the-design-of-its-phase-2-oba-clinical-study-in-9rclxhz8bt93.html

TheTradeXchange Posted - 04/29/24

$BPTS Biophytis is Deploying its Partnership Strategy in Obesity

Stock_Titan Posted - 04/29/24

$BPTS Biophytis is Deploying its Partnership Strategy in Obesity https://www.stocktitan.net/news/BPTS/biophytis-is-deploying-its-partnership-strategy-in-ombsxouvdzf8.html

lecorb Posted - 04/26/24

$BPTS The symbol you entered, BPTS, changed to BPTSY.

Stumphead Posted - 04/26/24

$BPTS this is kind of confusing. reverse split couple days ago and tomorrow otc but one was called ADRs and the other ADSs?

Trading1st Posted - 04/25/24

$BPTS hope this goes under a dollar within 10 days so it gets delisted. We need to show companies that a R/S is never the answer.

JimBull Posted - 04/25/24

$BPTS recent split with 300k float, could be next $BACK

Jamestocksdn Posted - 04/25/24

$BPTS i said R/S :)

Stock_Titan Posted - 04/24/24

$BPTS Biophytis Announces Transfer of ADSs to OTC Market https://www.stocktitan.net/news/BPTS/biophytis-announces-transfer-of-ad-ss-to-otc-hfwj9jyqza5p.html

AndersKingern_ Posted - 04/24/24

$BPTS why can’t I buy this on RH anymore?

tradingtwenty Posted - 04/24/24

Top 5 stocks by smallest market cap that have trended in the past 24 hours: $SMFL 532.63K 🔥 $WINT 2.9M $BPTS 2.92M $CSSE 4.93M $PALI 5.04M Link: https://tradingtwenty.com/dashboard/trending/past

NorrisChuck Posted - 04/23/24

Interesting reverse split movement today with $MYSZ $PIRS $ZAPP $BPTS . $MYSZ - $2.6m market cap - 445k shares $PIRS - $14.8m market cap - 1.2m shares $ZAPP - $13.5m market cap - 2.9m shares $BPTS - 2.5m market cap - 260k shares